Skip to content

Stress Hyperglycemia and Acute Ischemic Stroke

Stress Hyperglycemia as a Prognostic Factor in Acute Ischemic Stroke Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04408768
Enrollment
80
Registered
2020-05-29
Start date
2018-05-17
Completion date
2019-08-20
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Hyperglycemia

Brief summary

Whereas diabetes mellitus is clearly a risk factor for the occurrence of stroke and for its poor prognosis, hyperglycemia per se is also linked to increased morbidity and mortality in stroke patients.Therefore, the objective of this work was to study the glycemic status of acute ischemic stroke patients and to assess its impact on stroke outcome.

Detailed description

Using PASS program, setting alpha error at 5% and power of 80%, the total sample size was estimated to be 80 cases. The NIHSS was used as a primary outcome; 40 cases were needed in each group. Secondary outcomes were hemorrhagic transformation, hospital stay duration, mechanical ventilation, need for vasopressors, and 30-days mortality.

Interventions

OTHERstandard protocol for stroke patients

Standard protocol for stroke patients

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Acute ischemic stroke within 24 hours of onset of symptoms

Exclusion criteria

* subdural hematoma * Transient ischemic attack * Subarachnoid hemorrhage * Hemorrhagic stroke * Major comorbidities Hyperglycemia on admission that was controlled (random blood sugar (RBS) \< 150 mg/dl) within 24 hours with insulin therapy, diabetic * Ketoacidosis * RBS less than 70 mg/dl on admission

Design outcomes

Primary

MeasureTime frameDescription
National Institutes of Health Stroke Scale (NIHSS)30 daysThe NIHSS score categorized into: no stroke symptoms (0), mild stroke (1-4), moderate stroke (5-15), moderate to severe stroke (16-20), and sever (21-42)

Secondary

MeasureTime frameDescription
30-days mortality30 daysHemorrhagic transformation, the length of hospital stay, need for mechanical ventilation and vasopressors and 30-days mortality

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026